Meeting Micronutrient Requirements for Health and Development:
An Update M JAHANGIR ALAM 1 , R MOBARAK 2 , HS KAMRUL ALAM 2 , M SHAFIUL HAQUE 2 , M ABU TAYAB 2 morbidity and mortality among the underprivileged preschool children in several developing countries 7 . The purpose of this paper was to summarize the current knowledge on micronutrient deficiencies and their role in reducing morbidity and mortality during childhood.
Vitamin A Vitamin A has been termed as an anti-infectious agent plays an important role in visual system. 8 Vitamin A deficiency (VAD) impairs numerous body functions and can lead to many adverse health consequences including xerophthalmia (dry eyes), infections, morbidity, mortality, sub-optimal physical growth and anemia 8 . VAD is a major nutritional public health problem in the developing world. According to the latest report of the WHO, globally about 190 million preschool-aged children and 19.1 million pregnant women are vitamin A deficient (i.e. serum retinol < 0.70 ìmol/l) 9 . This corresponds to 33.3% of preschoolaged children and 15.3% of pregnant women in populations at risk of VAD. According to current estimates, 122 countries are classified as having a moderate to severe public health problem based on biochemical VAD in preschool-aged children, and 88 countries based on biochemical VAD in pregnant women 9 . Xerophthalmia, resulting from VAD is the primary preventable cause of blindness and of the world's children with xerophthalmia, nearly half reside in South or South-East Asia, of whom more than 85% live in India 10 . About 5.2 million preschool-aged children and 9.8 million pregnant women suffer from night blindness, which represents 0.9% and 7.8% of the population at risk of VAD, respectively. The estimates show that Africa and South-East Asia contain the highest proportions of preschool-aged children and pregnant females with biochemical VAD and night blindness 9 . Evidence from community trials has shown that vitamin A supplementation (VAS) reduces all-causes of mortality and diarrhea and measles specific mortality 11 . It also reduces incidence of measles and diarrhea infection 11 . VAS has also been shown to reduce prevalence of xerophthalmia and night blindness 11 . VAS as an adjunct in the treatment of measles has been shown to reduce mortality, pneumonia-specific mortality and incidence of croup 12 
Vitamin A supplementation:
The WHO recommends VAS for young children at a dose of 50,000 IU for infants <6 months of age, 100,000 IU for infants 6-12 months of age and 200,000 IU for children over 12 months of age, every 4 to 6 months (WHO 1997) 16 . The international community, recommends for a target of all children between the ages of 6 months and 5 years, in all countries where over 70 in 1,000 children die before the age of 5, as this is the internationally accepted proxy to indicate that vitamin A deficiency is a public health problem 17 . However, worldwide, a large proportion of children receiving it are neither vitamin A deficient nor stunted nor wasted. The effect of such a public health policy on this population needs to be carefully assessed.
Mortality outcomes: VAS in > 6 month old children
In Indonesian children who received massive dose of vitamin A supplements, had a 34 percent lower mortality from all causes than those not receiving the supplement 18 . A meta analysis of these initial studies concluded that VAS to measles hospitalized patients was highly protective for mortality. And, when given periodically to children at the community level, it decreased overall mortality 19 .
Mortality outcomes: Children 1-5 months of age
Studies where children were supplemented with vitamin A between 1 and 5 months of age did not show any positive effect on overall mortality 20 . Plausible explanations for these findings have focused on differences in environmental influences on this age group in relation to older infants (e.g. the protection of breast feeding against malnutrition and infection) Whether this could be explained by the interactions with vaccines given at this age, such as inactivated DTP vaccine, with vitamin A need to be further investigated 29 .
Even more controversial, VAS has been shown, not only not be beneficial, but detrimental in pediatric population. In a blinded, randomized controlled trial (RCT) performed in Mexico 30 , where measles vaccination coverage is very high and mortality in children < 5 years has been estimated in 17.4/1000 live births (2009) (Information from DGIS, SS Mexico), VAS to infants 6-15 mo was associated with a 27% increase in diarrheal disease and a 23% increase in cough with fever. The authors postulated that the increase in diarrhea in this study might reflect the effect of VAS to down-regulate the Th1 response, which protects against rotavirus. Similarly, they speculated that negative respiratory outcomes might be explained by the adverse effect of VAS in respiratory syncytial virus infections 31 . A meta analysis by Chen et al 32 concluded that VAS does not have a universal protective effect as prophylaxis for LRTI in children; indeed, three studies showed an increase in respiratory morbidity associated with VAS.
Folate and vitamin B12: function and importance in cognitive development

Biochemical Function of Folate and Vitamin B12:
The importance of folate and vitamin B12 for healthy neurological development and function is unquestioned. As essential co-factors for one-carbon metabolism, folate and vitamin B12 are required for biological methylation and DNA synthesis. Methylation activity is essential for many processes that are critical for central nervous function, such as the epigenetic regulation of gene expression by DNA and histone methylation, the methylation of myelin basic protein and membrane phosphatidylcholine, the synthesis of hormones and neurotransmitters such melatonin and epinephrine, and the inactivation of dopamine and catecholamines. Folate (in the form of 5-methyltetrahydrofolate) and vitamin B12 are required in all tissues to maintain adequate cellular methionine, which in turn is converted to S-adenosylmethionine (SAM) the universal methyl-donor for these reactions. Folate and B12 deficiency inhibit methylation and cause homocysteine to accumulate in circulation. Homocysteine may be cytotoxic and mildly elevated plasma homocysteine is associated with increased risk of neurodegnerative and cardiovascular disease. By increasing choline utilization or by depleting membrane phosphatidylcholine, folate deficiency might also indirectly limit the synthesis of the key neurotransmitter acetylcholine. Folate is needed to synthesize thimidylate and purine nucleotides. Thus, folate deficiency can compromise DNA replication and integrity. Vitamin B12 serves as a coenzyme for methylmalonyl-CoA mutase which catalyzes the final step in the mitochondrial degradation of odd chain fatty acids and branched amino acids. These biochemical effects of deficiency can be theoretically linked to the observed neuropathological, cognitive and developmental abnormalities that are associated with deficiency of these vitamins 33 .
Neurological consequences of acquired and congenital defects in one-carbon metabolism
The importance of folate and vitamin B12 for healthy brain development and function is evident. Severe acquired deficiencies of vitamin B12 and folate manifest with either haematological or neurological abnormalities or a combination of both 34 . The primary neurological feature is a progressive neuropathy in which sensation and motor control are gradually lost, typically beginning with the lower limbs 35 . In addition, these conditions are often accompanied by behavioral changes ranging from mild irritability to severe depression, hallucinations, confusion and memory loss 36 .
Symptoms of clinical deficiency can be treated with intramuscular injections and high dose oral supplementation, leading to hematologic and neurologic recovery; however in the long term, resolving the deficiency and acute pathology does not guarantee full restoration of cognitive development 37 .
Sub-clinical deficiencies in CNS development and aging
The neuropathology common to both congenital and severe acquired vitamin B12 and folate deficiencies include increased risk of neural tube defects (NTDs) among children born to mothers with low folate status, and increased risk of cognitive impairment, depression, Alzheimer's disease and stroke among older adults.
With respect to aging, the association between low B-vitamin status and increased risk of neurodegenerative disease has been extensively reviewed 38 . Data from over 100 observational cross sectional and prospective studies, encompassing over 50,000 subjects in total, provides compelling evidence for the association with approximately 90% of the studies reporting significant associations and the remainder not. Taken together, they provide the basis for the tenable hypothesis that "low-normal intake or blood concentrations of B-vitamins (folate, B12 and B6) and/or moderately elevated plasma total homocysteine increase the risk of brain atrophy and developing cognitive impairment in the elderly 33, 38 .
Early observations that poor folate status is associated with increased risk of spina bifida and anencephaly led to highly successful clinical trials in which use of periconceptual folic acid supplements reduced the risk of incident NTDs by as much as 50 percent or more 39 .
Folate and B12 supplementation and cognitive development The upper limit of folate intake for adults was conservatively set at 1 mg per day out of concern for the possibility that in individuals with frank B12 deficiency, high folate might either exacerbate the symptoms or "mask" the associated anemia, delaying early detection and treatment and thus allowing it to progress. Cross sectional data from the NHANES and SALSA cohorts show that the metabolic effects of vitamin B12 deficiency are more pronounced in adults with high folic acid intake. Irrespective of B12 status, high folic acid intake has also been observed to associate with more rapid cognitive decline in older adults and with decreased immune function in older post-menopausal women 40, 41 .
Iron
Iron is an essential mineral for human development and function. It is required for Hemoglobin and is critical for motor and cognitive development in childhood, and for physical activity in all humans 42 . Iron is also critical to the health of a pregnant mother and her unborn child. A woman needs more iron during pregnancy because the fetus and placenta both need additional iron. Iron supplementation during pregnancy, lowers the risk of maternal mortality due to haemorrhage, the cause of more than 130,000 maternal deaths each year 14 . Supplementation also helps to lower the risks of premature birth and low birth weight. Studies have shown that infants with anaemia caused by iron deficiency have lower mental scores and lower motor scores than infants without anaemia 43 .
The influence of inflammatory disorders and infection on iron absorption and the efficacy of iron fortified foods Introduction
Approximately 90% of daily iron needs can be met by the re-utilization of red cell iron after the breakdown of circulating red cells at the end of their natural life span. Although there is no physiological mechanism for active iron excretion from the body, there are obligatory iron losses from skin, intestine and urinary tract and additional losses during menstruation in women of child bearing age. To maintain iron balance, obligatory and menstrual iron losses, plus the iron required for growth in infants, children, and adolescents must come from the diet. This represents about 1-2 mg of absorbed iron per day. Many young women, infants and children fail to meet their iron needs from diet and these population groups make up the majority of the 2 billion people worldwide estimated to be iron deficient 44 . The situation is worse in the developing world due to low iron bioavailability from plant based diets and iron deficiency has more serious negative health and economic consequences including poor pregnancy outcome, poor cognitive development in children, and decreased physical performance and productivity 45 .
Iron fortified foods often contain inhibitors of iron absorption such as phytic acid and polyphenols in cereal and legume foods 46 and calcium in milk products 47 . In order to overcome the negative effects of these inhibitors, the food manufacture usually adds ascorbic acid, although NaFeEDTA and phytase can also be added 48 .
There is an inverse correlation between iron status and iron absorption 49 with a 50% decrease in iron stores doubling of iron absorption, although the magnitude of the inhibitory or enhancing effects are independent of iron status. Genetic disorders, nutritional deficiencies, infection and inflammation can also influence iron absorption 50 . Vitamin A deficiency can influence several stages of iron metabolism and riboflavin deficiencies may decrease iron incorporation into hemoglobin. Chronic inflammation 51 and obesity 52 increase hepcidin expression and would be expected to decrease iron absorption 53 .
Iron metabolism during infection and inflammation
Iron needed for new red cell synthesis and for replenishing iron enzymes and myoglobin is transported to the bone marrow or body tissues via transferrin in the plasma. The passage of iron into the plasma is mediated via the transport protein ferroprotein situated on the cell membrane 54 and its entry is strictly controlled by the regulatory hormone, hepcidin. This protein is secreted by the liver when iron status is adequate and inhibits the transport of iron into the plasma from both the macrophages and the intestinal cells 55 . Hepcidin binds ferroprotein at the cell membrane, causing internalization and degradation 56 and when iron status is low, hepcidin release from the liver is decreased and iron absorption is maximized.
The innate immune response to microbial infection is to increase hepcidin via an inflammatory response and to restrict microbial growth by restricting the entry of iron into the plasma 57 . The anemia of infection results from an interruption in the recycling of red cell iron. Macrophage iron is not released resulting in insufficient iron for erythropoiesis. The outcome of many infectious diseases depends on preventing the invading pathogen from obtaining its iron supply, and provision of high iron doses to an infected patient can worsen the infection. In addition to preventing iron release from the macrophage, the inflammatory response would also be expected to prevent iron release from the mucosal cell and thus restrict iron absorption.
Obesity and overweight in relation to iron absorption and the efficacy of iron fortified foods
American national surveys have consistently shown that overweight toddlers, children, adolescents and adults are more likely to be iron deficient than their normal weight counterparts and recent evidence suggests that adiposity related inflammation may play a central role through its regulation of hepcidin 52 . In a recent Swiss study, overweight children were reported to consume similar amounts of bioavailable iron as normal weight children but have a lower iron status, higher serum hepcidin and higher subclinical inflammation as measured by IL-6 and C-reactive protein (CRP) 58 .
Zinc
Zinc is the second most abundant transition metal in humans after iron. It is an essential part of about 100 specific enzymes and also serves as structural ions in transcription factors 59 .The association of zinc deficiency in children with growth retardation and hypogonadism was first described in 1963 from Iran 60 and it is now well established from animal and human studies that zinc plays a critical role in cellular growth, cellular differentiation and metabolism 61 and in turn promotes immunity, resistance to infection, and the growth and development of the nervous system 60 . Although zinc deficiency is increasingly being recognized as a widespread problem, there is very limited nationally representative data on the magnitude and severity of this deficiency 62 . Some of this is due in part to the lack of reliable biomarkers of zinc status. Recently, Wuehler et al., using data from national food balance sheets compiled by the Food and Agricultural Organization, estimated that 20 % of the world's population is at risk of low zinc intakes 63 . The global prevalence of low intakes by region indicates that 26 % of population in South Asia and 28 % in Sub-Saharan Africa are at risk deficiency 64 . Therapeutic zinc supplementation as an adjunct in the treatment of diarrhea has been shown to reduce the duration of acute diarrhea by 0.5 days and that of persistent diarrhea by 0.68 days. Preventive zinc supplementation reduces incidence of diarrhea by 20 % and that of pneumonia by 15 % 65 . Preventive zinc supplementation has been shown to reduce rate of stunting as well 66 . In 2004, WHO and UNICEF formulated a new recommendation to administer zinc for 10 to 14 days as an adjunct treatment for diarrhea, along with low-osmolarity oral rehydration solutions (ORS) and continuation of feeding 67 . Since then WHO and UNICEF in collaboration with USAID and Johns Hopkins University has worked to ensure the availability of zinc products 68 and about 91 million tablets had been provided in year 2008 69 . Despite all these efforts zinc supplementation is not part of national programs around the globe. Only 46 countries have adopted zinc policy as part of their national child health policy 70 . It is therefore required to scale up the zinc supplementation and it should be incorporated into national diarrhea management policy.
Iodine
Iodine is the key element required for thyroid hormone synthesis, and is also important for brain development during fetal and early years of life 70 . Children born to iodine-deficient mothers may appear normal at birth but might have suffered brain damage and loss in IQ points, affecting their ability to develop to their full potential. These seemingly normal children will later have difficulty learning in school and staying in school. It has been shown that in communities where iodine intake is sufficient, average IQ is shown to be on average 13 points higher than in iodine deficient communities 70 . According to an estimate about 2 billion people have insufficient iodine intake around the globe and about 31.5% of school-age children (266 million) have insufficient iodine intake 71 . Salt iodization is one of the exemplary success stories of food fortification offering great benefits for the intellectual health of nations that have embraced it 72 . Thirty-four developing countries have achieved the universal salt iodization goal, and an additional 38 countries are considered 'on track' for elimination of iodine deficiency disorders 72 . Despite this progress, many countries are lagging far behind. Twenty-four countries have experienced no growth in coverage rates or have even experienced a decline since the mid-1990s 72 .
Intervention Strategies to Address Multiple Micronutrient Deficiencies in Early Childhood Introduction
Micronutrient deficiencies are widespread and are a major global health problem worldwide 73 . World Health Organization (WHO) estimates that more than 2 billion people are deficient in key vitamins and minerals, particularly vitamin A, iodine, iron and zinc. Most of these people live in low income countries and are typically deficient in more than one micronutrient. 74 Globally, about 1.62 billion people are anemic with the highest prevalence in preschool age children (47%) and the second highest in pregnant women (42 %). According to the latest report of the WHO, globally about 190 million preschool-aged children and 19.1 million pregnant women are vitamin A deficient (i.e. serum retinol < 0.70 ìmo l/l) 75 . Approximately 100 million women of reproductive age suffer from iodine deficiency 76 . An estimated 82% of pregnant women worldwide have inadequate intakes of zinc to meet the normative needs of pregnancy 77 . Suboptimal vitamin B6 and B12 status has been observed in many developing countries 78 .
Maternal Micronutrient Supplementation during Pregnancy
In 1999 the UNICEF/WHO/UN University proposed a prenatal supplement UNIMAPP containing fifteen micronutrients, including iron and folic acid which could provide one recommended daily allowance of each and potentially replace standard iron-folate supplements for pregnant women in low and middle income countries. A Cochrane review on the subject 81 indicated that compared to iron-folate, multiple micronutrient supplementation had comparable effect on maternal anemia and had a significant effect on incidence of low birth weight (LBW) babies and that of small for gestational age babies 82 has shown that MMN supplementation during childhood has a significant effect on academic
Conclusions
Micronutrients like vitamin A, Vit B12, foliccid, iron, zinc and iodine are important for growth and survival of children. Given the wide prevalence of multiple micronutrient deficiencies in malnourished children in developing countries, the challenge is to implement intervention strategies that combine appropriate infant and young child feeding with micronutrient interventions at scale. Emerging data from community intervention trials now provide evidence that this is both tangible and can lead to alleviation of childhood under nutrition. Multiple micronutrients supplementation during pregnancy and early childhood in populations at risk is an effective way of prevention of micronutrient deficiencies. Further studies are needed on cost effectiveness and delivery strategies in health system settings. 
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